Abstract
Severe bone loss is a critical issue in trauma and it requires complex techniques to preserve limb form and function. Regenerative medicine, using stem cells and molecular biology, might be useful to enhance bone healing in severe bone loss. Between 2017 and 2018, 4 patients showed severe bone loss. In all of them, the use of stem cells was added to fixation with a cortical graft. Fracture healing occurred in a range of 3 to 8 months. In our experience, the use of stem cells, in association with bone graft and stable fixation, was able to achieve bone healing even in case of severe bone loss.
Similar content being viewed by others
Bibliografia
Keating JF, Simpson AHRW, Robinson CM (2005) The management of fractures with bone loss. J Bone Jt Surg Br 87:142–150
Gustilo RB, Anderson JT (2002) JSBS classics. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones. Retrospective and prospective analyses. J Bone Jt Surg, Am 84:682
Tarantino U, Cerocchi I, Scialdoni A et al. (2011) Bone healing and osteoporosis. Aging Clin Exp Res 23(Suppl 2):62–64
Giannoudis PV, Einhorn TA, Marsh D (2007) Fracture healing: a harmony of optimal biology and optimal fixation? Injury 38(Suppl 4):S1–2
Giannoudis PV, Einhorn TA, Marsh D (2007) Fracture healing: the diamond concept. Injury 38(Suppl 4):S3–6
Giannoudis PV, Ahmad MA, Mineo GV et al. (2013) Subtrochanteric fracture non-unions with implant failure managed with the “Diamond” concept. Injury 44:S76–81
Akpancar S, Tatar O, Turgut H et al. (2016) The current perspectives of stem cell therapy in orthopedic surgery. Arch Trauma Res 5:e37976
Grayson WL, Bunnell BA, Martin E et al. (2015) Stromal cells and stem cells in clinical bone regeneration. Nat Rev Endocrinol 11:140–150
Marcucio RS, Nauth A, Giannoudis PV et al. (2015) Stem cell therapies in orthopaedic trauma. J Orthop Trauma 29(Suppl 12):S24–27
Wang X, Wang C, Gou W et al. (2018) The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model. Stem Cell Res Ther 9:272
Liao Y, Zhang X-L, Li L et al. (2014) Stem cell therapy for bone repair: a systematic review and meta-analysis of preclinical studies with large animal models. Br J Clin Pharmacol 78:718–726
McEwan JK, Tribe HC, Jacobs N et al. (2018) Regenerative medicine in lower limb reconstruction. Regen Med 13:477–490
Tomford WW (1995) Transmission of disease through transplantation of musculoskeletal allografts. J Bone Jt Surg, Am 77:1742–1754
Arrington ED, Smith WJ, Chambers HG et al. (1996) Complications of iliac crest bone graft harvesting. Clin Orthop 329:300–309
Ohgushi H, Kotobuki N, Funaoka H et al. (2005) Tissue engineered ceramic artificial joint–ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26:4654–4661
Hernigou P, Poignard A, Beaujean F, Rouard H (2005) Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Jt Surg, Am 87:1430–1437
Papakostidis C, Tosounidis TH, Jones E, Giannoudis PV (2016) The role of “cell therapy” in osteonecrosis of the femoral head. A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop 87:72–78
Hernigou P, Poignard A, Zilber S, Rouard H (2009) Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 43:40
Kitoh H, Kitakoji T, Tsuchiya H et al. (2004) Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis–a preliminary result of three cases. Bone 35:892–898
Toro G, Moretti A, Toro G et al. (2017) Surgical treatment of neglected hip fracture in children with cerebral palsy: case report and review of the literature. Clin Cases Miner Bone Metab 14:317
Toro G, Lepore F, Calabrò G et al. (2019) Humeral shaft non-union in the elderly: results with cortical graft plus stem cells. Injury 50(Suppl 2):S75–79
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori G. Toro, L. Prinzo, M. Gison, C. Di Fino, A. De Cicco, A. Braile, F. Lepore, A. Toro e A. Schiavone Panni dichiarano di non aver alcun conflitto d’interesse.
Consenso informato e conformità agli standard etici
Tutte le procedure descritte nello studio e che hanno coinvolto essere umani sono state attuate in conformità alle norme etiche stabilite dalla dichiarazione di Helsinki del 1975 e successive modifiche. Il consenso informato è stato ottenuto da tutti i pazienti inclusi nello studio.
Human and Animal Right
L’articolo non contiene alcuno studio eseguito su esseri umani e su animali da parte degli autori.
Rights and permissions
About this article
Cite this article
Toro, G., Prinzo, L., Gison, M. et al. Innesti di cellule staminali mesenchimali nelle grandi perdite di sostanza. LO SCALPELLO 33, 258–263 (2019). https://doi.org/10.1007/s11639-019-00331-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11639-019-00331-1